Several cell cycle proteins, including D- and E-type cyclins, CDKs (CDK2, CDK4, CDK6), PLK1, and Aurora kinases, are commonly overexpressed in cancers and contribute to tumor development and progression [43]. This evidence concerns the gene CDK2 and neoplasm.